{'text': 'Celgene sets high standard for biotech', 'publisher': {'href': 'https://www.spokesman.com', 'title': 'The Spokesman Review'}, 'created_at': 'Sun, 23 Aug 2015 07:00:00 GMT', 'description': 'Celgene sets high standard for biotech  The Spokesman Review', 'url': 'https://news.google.com/rss/articles/CBMijgFBVV95cUxOREJkQ2RhMGZWV2otQ21xTlVjeGJ2OGhpdHQyd2xSX0NKVWUzWWt6dnprWGZORXU0QUtMQVZkalNfV2lNbWZvMTVkdmJHNlhrSVhBU3pvdk9RRFZmVFZfeFpQd3d3c0VhdjNiY2pMSWRVVkpFc2lFYmhndXdHc3BrcWN0TU5ZVEFfdFgzRjRB?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'New Tool Calculates Cost-Benefit Analysis for Cancer Treatments - Voice of America', 'publisher': {'href': 'https://www.voanews.com', 'title': 'Voice of America - VOA News'}, 'created_at': 'Mon, 24 Aug 2015 07:00:00 GMT', 'description': 'New Tool Calculates Cost-Benefit Analysis for Cancer Treatments  Voice of America - VOA News', 'url': 'https://news.google.com/rss/articles/CBMihgFBVV95cUxPMDA4UFd5blQ5VjFUSy1LYUtxeVVhSF9GeGY1RkJaZUwybjVFbG80bXZaa2dfZEREcVFTbXoybktENVA1NzU5aW9MTmpscFI5X3llOUNnd21Bb2Iwd2NGMC1uMXdvaEJMMTVrZHFiNDFLWEJHRWtYRXR5djFaQ3FjRzlBaGtiQdIBiAFBVV95cUxNbmp3bEFiM0JydUhTYUU0bkNrd3p1c0pBZ2x6SXRQeFdmYXo2UTVaRlhJVzlVQnUybGxyR1RnbEplNlpGZzBzN3Eza21vOFBISEpaYzUxS0xWa3hvZC15cWVrN1UtQWZrbUZyd0FCZURnY2g5azN5TnZqVEd5N1hBUEFoLXBJVlpQ?oc=5&hl=en-US&gl=US&ceid=US:en'}
